Akero Therapeutics (AKRO) Announces Proposed 4.75M Common Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Akero Therapeutics (AKRO) Prices 5.228M Share Common Offering at $36/Sh
July 8, 2020 5:58 AM EDTAkero Therapeutics, Inc. (NASDAQ: AKRO) announced today the pricing of an underwritten public offering of 5,228,166 shares of its common stock at a public offering price of $36.00 per share, before underwriting discounts and commissions. All of the shares in the offering are to... More
